Meningococcal vaccines
Clinical trials for Meningococcal vaccines explained in plain language.
Never miss a new study
Get alerted when new Meningococcal vaccines trials appear
Sign up with your email to follow new studies for Meningococcal vaccines, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New meningitis vaccine trial aims to shield babies from deadly infection
Vaccine Recruiting nowThis Phase 3 trial tests a new vaccine designed to protect infants aged 3 to 5 months against four strains of meningococcal bacteria that cause meningitis and sepsis. About 880 healthy babies will receive either the experimental vaccine or a licensed comparator vaccine. Researche…
Matched conditions: MENINGOCOCCAL VACCINES
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
New meningitis vaccine for toddlers shows promise in major trial
Vaccine Recruiting nowThis study tests a new vaccine to protect young children (12-23 months old) against four types of meningococcal bacteria that can cause meningitis. About 1,040 toddlers will receive either the new vaccine or an existing one to see if the new vaccine is as safe and effective. The …
Matched conditions: MENINGOCOCCAL VACCINES
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
New meningitis vaccine trial aims to protect babies
Vaccine Recruiting nowThis Phase 3 trial tests a new vaccine against four types of meningococcal bacteria (A, C, Y, W135) that cause meningitis. About 1,040 healthy infants aged 6 to 11 months will receive either the experimental vaccine or a licensed comparator. Researchers will measure immune respon…
Matched conditions: MENINGOCOCCAL VACCINES
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
Massive study tracks meningitis trends in 10,000 kids
Knowledge-focused Recruiting nowThis study is a national observatory that will follow 10,000 children and newborns with bacterial meningitis. Researchers aim to understand which bacteria are causing infections, how often treatments fail, and how well vaccines are working. The goal is to improve future treatment…
Matched conditions: MENINGOCOCCAL VACCINES
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC